S
Sedigheh Eskandari
Researcher at Shiraz University of Medical Sciences
Publications - 8
Citations - 34
Sedigheh Eskandari is an academic researcher from Shiraz University of Medical Sciences. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 1, co-authored 4 publications receiving 13 citations. Previous affiliations of Sedigheh Eskandari include Shiraz University.
Papers
More filters
Journal ArticleDOI
Small extracellular vesicles (sEVs): discovery, functions, applications, detection methods and various engineered forms.
Manica Negahdaripour,Manica Negahdaripour,Hajar Owji,Sedigheh Eskandari,Mozhdeh Zamani,Bahareh Vakili,Navid Nezafat,Navid Nezafat +7 more
TL;DR: SEVs, as an important class of EVs, have a crucial role in distinct biological functions and shedding light on different structural and molecular aspects of sEV has led to their application in various therapeutic, diagnostic, and drug delivery fields.
Journal ArticleDOI
Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer’s: a Comprehensive Review
Sedigheh Eskandari,Soraya Sajadimajd,Loghman Alaei,Zhaleh Soheilikhah,Hossein Derakhshankhah,Gholamreza Bahrami +5 more
TL;DR: In this article, the most common signaling cascades implicated in the pathogenesis of Alzheimer's disease and stroke including notch, autophagy, inflammatory, and insulin signaling pathways were reviewed and current therapeutic strategies including natural and synthetic pharmaceuticals aiming modulation of respective signaling factors were scrutinized to ameliorate neural deficits in AD and stroke.
Journal ArticleDOI
In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach
TL;DR: In this paper , a reverse vaccinology approach was implemented to design a mRNA vaccine against BKV by identifying the most antigenic proteins of this pathogen and the final epitopes were selected according to antigenicity, toxicity, allergenicity, and cytokine inducibility scores.
Posted ContentDOI
Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
TL;DR: A combinatorial vaccine against HSV, CT, and HPV that could potentially incite humoral and cellular immunities, which are critical for protection against HPV, HSV-2, and chlamydia trachomatis is designed.